Endometriosis. Endometriosis of Ovary
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, 10 patients with endometriosis are treated orally for 10 weeks with a daily dose of 120 mg of nanocell curcumin supplement (40 mg). Nano
Sponsors
Iranian academic center for education culture and research
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age between 20-40 Years Endometriosis With Grade 2 and 3
Exclusion criteria
Exclusion criteria: No ovulation Male factor infertility Pelvic organ prolapse Congenital adrenal hyperplasia Thyroid hormone disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of serum levels of sex hormone. Timepoint: Before taking the drug and 10 weeks after taking the drug. Method of measurement: Eliza Kit.;Evaluation of biochemical factors. Timepoint: Before taking the drug and 10 weeks after taking the drug. Method of measurement: Abnova commercial kits using ELISA method.;Measurement of Plasma Curcumin Levels. Timepoint: Before Taking the Drug and 10 Weeks After Taking the Drug. Method of measurement: Negative Electrospray Ionization (ESI) and Data are Analyzed Using MassLynx v4.0 Software.;Apoptosis Levels. Timepoint: Before Taking the Drug and 10 weeks After Taking the Drug. Method of measurement: Tunnel Kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fertility Rate. Timepoint: One Day After Injection of Sperm into the Cytoplasm of the Oocyte. Method of measurement: Fertilization is Seen with an Inverted Microscope.;Embryo Quality. Timepoint: Three Days After Sperm is Injected into the Cytoplasm of the Oocyte. Method of measurement: Embryo Quality is Assessed Based on the Number of Cells and the Number of Blastomeres and the Fragmentation of the Blastomeres and is Observed Under an Inverted Microscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Verdi
Iranian academic center for education culture and research
Outcome results
None listed